80 percent of cervical cancers found to be preventable with latest 9-valent HPV vaccine
The new 9-valent human papillomavirus vaccine, can potentially prevent 80 percent of cervical cancers in the United States, if given to all 11- or 12-year-old children before they are exposed to the virus. The study also found the 9-Valent vaccine, under the trademark of Gardasil-9, has the potential to protect against an additional 8 percent of oropharyngeal cancers, which include the base of the tongue and tonsils. This disease is the second-most-common HPV-associated cancer. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - May 11, 2015 Category: Science Source Type: news
Tonsillectomy Appears to Protect Against Tonsil CancerTonsillectomy Appears to Protect Against Tonsil Cancer
Danish data also correlate the decline of tonsillectomies and the rise of oropharyngeal cancer over time. Medscape Medical News (Source: Medscape Hiv-Aids Headlines)
Source: Medscape Hiv-Aids Headlines - May 6, 2015 Category: Infectious Diseases Tags: HIV/AIDS News Source Type: news
HPV Vaccination Helps Prevent Head and Neck Cancer
Big news: A vaccination is available to prevent cancer. The vaccine, when given to preteens, can help prevent them from contracting oropharyngeal cancer, a head-neck cancer affecting the throat and tonsils. (Source: News_Room)
Source: News_Room - April 20, 2015 Category: Consumer Health News Source Type: news
By 2020, The Most Common HPV-Related Cancer Will Affect Men
While currently recommended for both boys and girls, the HPV vaccine was initially marketed -- and is still thought of -- as a way to protect young women and girls from cervical, vaginal and vulvar cancer. Boys, it's been commonly thought, should be vaccinated primarily to benefit herd immunity and any future female partners.
But a new analysis from researchers at the Princess Margaret Cancer Center in Toronto, Canada, points out that boys who get the vaccine receive important protection as well, not only against genital warts, but against HPV strains that cause oropharyngeal (mouth and throat) cancer.
"We believe this s...
Source: Science - The Huffington Post - April 20, 2015 Category: Science Source Type: news
HPV Shots for Boys Might Cut Cancer Costs (CME/CE)
(MedPage Today) -- Canadian study suggests vaccination would save money by preventing oropharyngeal cancer. (Source: MedPage Today Public Health)
Source: MedPage Today Public Health - April 14, 2015 Category: American Health Source Type: news
Vaccinating Boys Against HPV Could Prevent OPCVaccinating Boys Against HPV Could Prevent OPC
Vaccinating adolescent boys against the human papillomavirus (HPV) might be a cost-effective way of preventing oropharyngeal cancer (OPC), a statistical model has demonstrated. Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 13, 2015 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news
HPV vaccination of adolescent boys may be cost-effective for preventing oropharyngeal cancer
(Wiley) A new study indicates that vaccinating 12-year-old boys against the humanpapilloma virus may be a cost-effective strategy for preventing oropharyngeal squamous cell cancer, a cancer that starts at the back of the throat and mouth, and involves the tonsils and base of the tongue. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - April 13, 2015 Category: Global & Universal Source Type: news
Potential prognostic marker for recurrence of head and neck squamous cell carcinoma
The first evidence that the mediator complex subunit 15 (MED15) may play a crucial role in the pathophysiology of head and neck squamous cell carcinoma (HNSCC) has been discovered by researchers. MED15 overexpression was found to be associated with higher mortality rates in HNSCC patients with cancer recurrence, particularly in oral cavity/oropharyngeal tumors, according to the study. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - March 20, 2015 Category: Science Source Type: news
Researchers ID potential prognostic marker for recurrence of head and neck squamous cell carcinoma
(Elsevier Health Sciences) A new study provides the first evidence that the mediator complex subunit 15 (MED15) may play a crucial role in the pathophysiology of head and neck squamous cell carcinoma (HNSCC). MED15 overexpression was found to be associated with higher mortality rates in HNSCC patients with cancer recurrence, particularly in oral cavity/oropharyngeal tumors, according to the study published in the American Journal of Pathology. MED15 overexpression was also associated with heavy alcohol consumption, which is an HNSCC risk factor. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - March 20, 2015 Category: Cancer & Oncology Source Type: news
Researchers ID potential prognostic marker for recurrence of head & neck squamous cell carcinoma
(Elsevier Health Sciences) A new study provides the first evidence that the mediator complex subunit 15 (MED15) may play a crucial role in the pathophysiology of head and neck squamous cell carcinoma (HNSCC). MED15 overexpression was found to be associated with higher mortality rates in HNSCC patients with cancer recurrence, particularly in oral cavity/oropharyngeal tumors, according to the study published in The American Journal of Pathology. MED15 overexpression was also associated with heavy alcohol consumption, which is an HNSCC risk factor. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - March 20, 2015 Category: Global & Universal Source Type: news
HPV Vaccine Fights Cervical Cancer, and More
Human papillomavirus (HPV) causes cervical cancer; many people know that. But here’s a surprise: HPV also causes other increasingly common cancers. The good news is there‘s a powerful tool that prevents the virus’ spread and the cancers it causes: The HPV vaccine. It prevents oropharyngeal cancer (a head-neck cancer affecting the throat and tonsils), which is fast becoming the most common cancer caused by HPV, striking more men than women. The vaccine also prevents cervical cancer, which affects only women. (Source: News_Room)
Source: News_Room - March 10, 2015 Category: Consumer Health News Source Type: news
Cure Possible for Some HPV-Positive Oropharyngeal CancersCure Possible for Some HPV-Positive Oropharyngeal Cancers
Some patients with HPV-positive throat cancer can be cured, even after the disease has spread, Canadian researchers say. Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - February 17, 2015 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news
New research shows possibility of cure for HPV positive throat cancer patients
Researchers from Canada have shown for the first time that some patients with HPV positive oropharyngeal cancer can be cured, even after the disease has spread to other organs. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - February 12, 2015 Category: Science Source Type: news
New research shows possibility of cure for HPV positive throat cancer patients
(European Society for Radiotherapy and Oncology (ESTRO)) Researchers from Canada have shown for the first time that some patients with HPV positive oropharyngeal cancer can be cured, even after the disease has spread to other organs. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - February 12, 2015 Category: Cancer & Oncology Source Type: news
Impact of HPV on Treatment for Head and Neck CancerImpact of HPV on Treatment for Head and Neck Cancer
Find out why HPV-associated oropharyngeal carcinoma appears to be a distinct entity with different epidemiology, biology, and clinical outcomes. Annals of Oncology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - November 21, 2014 Category: Consumer Health News Tags: Hematology-Oncology Journal Article Source Type: news
